111 related articles for article (PubMed ID: 35550518)
1. Publisher Correction: Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma.
Lu C; Mahajan A; Hong SH; Galli S; Zhu S; Tilan JU; Abualsaud N; Adnani M; Chung S; Elmansy N; Rodgers J; Rodriguez O; Albanese C; Wang H; Regan M; Zgonc V; Blancato J; Krawczyk E; Gallicano GI; Girgis M; Cheema A; Iżycka-Świeszewska E; Cavalli LR; Pack SD; Kitlinska J
Nat Commun; 2022 May; 13(1):2729. PubMed ID: 35550518
[No Abstract] [Full Text] [Related]
2. Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma.
Lu C; Mahajan A; Hong SH; Galli S; Zhu S; Tilan JU; Abualsaud N; Adnani M; Chung S; Elmansy N; Rodgers J; Rodriguez O; Albanese C; Wang H; Regan M; Zgonc V; Blancato J; Krawczyk E; Gallicano GI; Girgis M; Cheema A; Iżycka-Świeszewska E; Cavalli LR; Pack SD; Kitlinska J
Nat Commun; 2022 Apr; 13(1):2323. PubMed ID: 35484119
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y/Y5 Receptor Pathway Stimulates Neuroblastoma Cell Motility Through RhoA Activation.
Abualsaud N; Caprio L; Galli S; Krawczyk E; Alamri L; Zhu S; Gallicano GI; Kitlinska J
Front Cell Dev Biol; 2020; 8():627090. PubMed ID: 33681186
[TBL] [Abstract][Full Text] [Related]
4. High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases.
Hong SH; Tilan JU; Galli S; Izycka-Swieszewska E; Polk T; Horton M; Mahajan A; Christian D; Jenkins S; Acree R; Connors K; Ledo P; Lu C; Lee YC; Rodriguez O; Toretsky JA; Albanese C; Kitlinska J
Oncotarget; 2015 Mar; 6(9):7151-65. PubMed ID: 25714031
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y Y5 receptor protein in the cortical/limbic system and brainstem of the rat: expression on gamma-aminobutyric acid and corticotropin-releasing hormone neurons.
Grove KL; Campbell RE; Ffrench-Mullen JM; Cowley MA; Smith MS
Neuroscience; 2000; 100(4):731-40. PubMed ID: 11036207
[TBL] [Abstract][Full Text] [Related]
6. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.
Tilan JU; Krailo M; Barkauskas DA; Galli S; Mtaweh H; Long J; Wang H; Hawkins K; Lu C; Jeha D; Izycka-Swieszewska E; Lawlor ER; Toretsky JA; Kitlinska JB
Cancer; 2015 Mar; 121(5):697-707. PubMed ID: 25387699
[TBL] [Abstract][Full Text] [Related]
7. Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures.
Gøtzsche CR; Nikitidou L; Sørensen AT; Olesen MV; Sørensen G; Christiansen SH; Ängehagen M; Woldbye DP; Kokaia M
Neurobiol Dis; 2012 Jan; 45(1):288-96. PubMed ID: 21884793
[TBL] [Abstract][Full Text] [Related]
8. Cloning and pharmacological characterization of the neuropeptide Y receptor Y5 in the sea lamprey, Petromyzon marinus.
Xu B; Sundström G; Kuraku S; Lundell I; Larhammar D
Peptides; 2013 Jan; 39():64-70. PubMed ID: 23178200
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological profile of the rat intestinal crypt peptide YY receptor vs. the recombinant rat Y5 receptor.
Goumain M; Voisin T; Lorinet AM; Balasubramaniam A; Laburthe M
Eur J Pharmacol; 1998 Dec; 362(2-3):245-9. PubMed ID: 9874177
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.
Tilan JU; Lu C; Galli S; Izycka-Swieszewska E; Earnest JP; Shabbir A; Everhart LM; Wang S; Martin S; Horton M; Mahajan A; Christian D; O'Neill A; Wang H; Zhuang T; Czarnecka M; Johnson MD; Toretsky JA; Kitlinska J
Oncotarget; 2013 Dec; 4(12):2487-501. PubMed ID: 24318733
[TBL] [Abstract][Full Text] [Related]
11. Molecular identification of the long isoform of the human neuropeptide Y Y5 receptor and pharmacological comparison with the short Y5 receptor isoform.
Rodriguez M; Audinot V; Dromaint S; Macia C; Lamamy V; Beauverger P; Rique H; Imbert J; Nicolas JP; Boutin JA; Galizzi JP
Biochem J; 2003 Feb; 369(Pt 3):667-73. PubMed ID: 12398768
[TBL] [Abstract][Full Text] [Related]
12. Ligand internalization by cloned neuropeptide Y Y5 receptors excludes Y2 and Y4 receptor-selective peptides.
Parker SL; Parker MS; Buschauer A; Balasubramaniam A
Eur J Pharmacol; 2003 Aug; 474(1):31-42. PubMed ID: 12909193
[TBL] [Abstract][Full Text] [Related]
13. The rabbit ileum: a sensitive and selective preparation for the neuropeptide Y Y5 receptor.
Pheng LH; Quirion R; Iyengar S; Fournier A; Regoli D
Eur J Pharmacol; 1997 Aug; 333(2-3):R3-5. PubMed ID: 9314048
[TBL] [Abstract][Full Text] [Related]
14. Central administration of Y5 receptor antisense decreases spontaneous food intake and attenuates feeding in response to exogenous neuropeptide Y.
Tang-Christensen M; Kristensen P; Stidsen CE; Brand CL; Larsen PJ
J Endocrinol; 1998 Nov; 159(2):307-12. PubMed ID: 9795372
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y Stimulates Proliferation and Migration of Vascular Smooth Muscle Cells from Pregnancy Hypertensive Rats via Y1 and Y5 Receptors.
Zhang P; Qi YX; Yao QP; Chen XH; Wang GL; Shen BR; Han Y; Gao LZ; Jiang ZL
PLoS One; 2015; 10(7):e0131124. PubMed ID: 26131716
[TBL] [Abstract][Full Text] [Related]
16. Expression of hypoxia inducible factor-dependent neuropeptide Y receptors Y1 and Y5 sensitizes hypoxic cells to NPY stimulation.
Medeiros PJ; Pascetta SA; Kirsh SM; Al-Khazraji BK; Uniacke J
J Biol Chem; 2022 Mar; 298(3):101645. PubMed ID: 35093384
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis.
Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Beck-Sickinger A; Lechan RM
Endocrinology; 2002 Dec; 143(12):4513-9. PubMed ID: 12446577
[TBL] [Abstract][Full Text] [Related]
18. Hypothalamic circuitry of neuropeptide Y regulation of neuroendocrine function and food intake via the Y5 receptor subtype.
Campbell RE; ffrench-Mullen JM; Cowley MA; Smith MS; Grove KL
Neuroendocrinology; 2001 Aug; 74(2):106-19. PubMed ID: 11474218
[TBL] [Abstract][Full Text] [Related]
19. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice.
Kanatani A; Mashiko S; Murai N; Sugimoto N; Ito J; Fukuroda T; Fukami T; Morin N; MacNeil DJ; Van der Ploeg LH; Saga Y; Nishimura S; Ihara M
Endocrinology; 2000 Mar; 141(3):1011-6. PubMed ID: 10698177
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
